Mananquil, Kim Judel .
HRN: 19-50-47 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
11/03/2022
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
11/03/2022
11/09/2022
IV DRIP
250 Mg
Q6
Worsening Cough
Waiting Final Action
Indication: Empiric Type of Infection: Pneumonia Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes